Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2021

Nov 23, 2021

33899_dirs_2021-11-23_d38bc261-5489-4833-bf08-fbec1095b977.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2021-11-04

Reporting Person: Chard Daniel R (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-04 Common Stock G 90610 Disposed 15716 Direct
2021-11-04 Common Stock G 90610 Acquired 90610 Indirect

Footnotes

F1: The reporting person transferred these shares to The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.

F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.